A group of researchers from the Graduate School of Medicine at Nagoya University in Japan have discovered the impact of microRNA (miRNA) on inflammation in lupus in mice. They identified two miRNAs that are downregulated in the disease and an uncommon situation that occurs in which multiple
Addressing the issue, Selena said to a fan, "I shake because of my medication of lupus," and added "Also read my disclaimer. I ain't no pro," reported by E News, a US based media company.
The findings of a recent study suggest that targeting iron metabolism in immune system cells may offer a new approach for treating systemic lupus erythematosus (SLE) -- the most common form of the chronic autoimmune disease lupus.
A new study suggests that restoring the balance of a protein in the blood could be a promising treatment option for systemic lupus erythematosus, also known as lupus, an untreatable autoimmune disease.
Patients taking efgartigimod, a drug being studied for use to treat chronic primary immune thrombocytopenia (ITP), exhibited a significantly greater improvement in platelet counts which are essential to clotting and stopping bleeding, compared to those taking a placebo, according to results
Engineered immune cells, known as CAR T cells, have shown the world what personalized immunotherapies can do to fight blood cancers. Now, investigators have reported highly promising early results for CAR T therapy in a small set of patients with the autoimmune disease lupus. Penn Medicine C
Type I interferon (IFN) is a strong immune activator found in high concentrations in the majority of patients with lupus, an autoimmune disease. In Arthritis & Rheumatology, researchers report positive results from the first placebo-controlled long-term trial of anifrolumab, a human mon
Leuven [Belgium], August 28 (ANI): In high-income areas like Europe and the United States, 10% of the population has been identified as having one or more autoimmune illnesses.